Psychemedics Revenue, Profits - PMD Annual Income Statement

Add to My Stocks
$20.6 $0.18 (0.88%) PMD stock closing price Aug 16, 2017 (Closing)

Financial statements provide us with a way to gain insights and undertake the fundamental analysis of a company. Checking Psychemedics stock price alone is not sufficient. The key financial statements of a company are the income statement, the balance sheet and the cash flow statement. When compared with the corresponding income statement from the past, the latest income statement shows how revenue has grown from $26.97M to $38.98M and how operating and non operating activities have impacted the PMD stock. Along with Psychemedics assets and Psychemedics free cash flow, profits as shown in profit and loss statement give key insights about the business. The profits have increased from $1.51M YoY and 2016 revenue is $38.98M. Psychemedics revenue for 2016 is $38.98M. View revenue and profit details for latest and last 10 financial years.

show more
Annual
Quarterly
View Previous Years
View Next Years
Fiscal year is Jan - Dec.2016201520142013201220112010200920082007
Psychemedics Net Sales or Revenues
38.98M26.97M29.2M26.87M25.22M24.08M20.1M16.95M22.94M24.56M
Cost Of Goods Sold (COGS)17.53M14.25M14.06M11.47M10.97M9.61M8.06M7.34M9.59M9.89M
Psychemedics Gross Profit
21.45M12.71M15.13M15.39M14.25M14.47M12.04M9.6M13.35M14.67M
Research & Development Expense1.41M1.63M1.34M0.82M0.82M0.6M0.48M0.46M0.47M0.48M
Selling General & Admin Expense9.92M9.61M9.1M8.86M8.49M8.06M7.14M6.55M8.16M7.04M
Income Before Depreciation Depletion Amortization10.11M1.47M4.68M5.7M4.93M5.8M4.41M2.58M4.7M7.13M
Depreciation Depletion Amortization----------
Non Operating Income-0.13M-0.12M-0.05M0.09M-0.01M0.02M0.04M0.3M0.41M
Interest Expense----------
Psychemedics Pretax Income
9.97M1.34M4.63M5.79M4.93M5.8M4.43M2.62M5.01M7.55M
Provision for Income Taxes3.29M-0.16M1.42M1.99M1.95M2.31M1.82M1.1M2.04M3.07M
Minority Interest----------
Investment Gains Losses----------
Other Income----------
Income Before Extraordinaries & Disc Operations6.67M1.51M3.2M3.8M2.97M3.48M2.61M1.52M2.96M4.48M
Extraordinary Items & Discontinued Operations----------
Psychemedics Net Income (Profit/Loss)
6.67M1.51M3.2M3.8M2.97M3.48M2.61M1.52M2.96M4.48M
Average Shares used to compute Diluted EPS5.47M5.41M5.38M5.32M5.27M5.24M5.23M5.21M5.25M5.3M
Average Shares used to compute Basic EPS5.47M5.41M5.36M5.3M5.26M5.23M5.21M5.19M5.22M5.21M
Income Before Nonrecurring Items6.68M1.51M3.21M3.81M2.98M3.49M2.61M1.53M2.97M4.48M
Income from Nonrecurring Items----------
Psychemedics Earnings Per Share Basic Net
1.220.280.600.720.570.670.500.290.570.86
Psychemedics Earnings Per Share Diluted Net
1.220.280.600.720.570.670.500.290.570.85
EPS Diluted Before Nonrecurring Items1.220.280.600.720.570.670.500.290.570.85
Preferred Dividends Acc Pd----------
Dividends Common----------
Dividend Per Share Common0.600.600.600.600.600.480.480.581.160.58
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years
Get Income statement for another ticker

The key things to look for in an income statement while doing Psychemedics stock analysis are:
  • Topline: A growing topline, as seen from the Psychemedics revenue chart, as is the case with Psychemedics indicates a growing business. One needs to compare the QoQ or YoY topline growth of PMD stock with its peers like AAC stock and QHC stock to see if the growth compares well with what can be expected for a company in that industry.
  • Bottom line: The word bottom line comes because it is usually the last line of the income statement and refers to the actual profits after deducting all expenses from the revenues. PMD stock had a healthy bottom line growth.
The income statement is also called the profit and loss statement. Apart from the income statement, one can check the Psychemedics historical stock prices to check how the price has moved with time. .

Psychemedics Income Statement - Key Financial Ratios

PE ratio (price earnings ratio)
15.2590
PS ratio (
price sales ratio
)
2.5883
Operating margin
22.1
Net profit margin
14.7
Dividend yield
2.91%